Decreased LRIG1 in fulvestrant-treated luminal breast cancer cells permits ErbB3 upregulation and increased growth

M. M. Morrison, M. M. Williams, D. B. Vaught, D. Hicks, J. Lim, C. McKernan, L. Aurisicchio, G. Ciliberto, C. Simion, Colleen A Sweeney, R. S. Cook

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Fingerprint

Dive into the research topics of 'Decreased LRIG1 in fulvestrant-treated luminal breast cancer cells permits ErbB3 upregulation and increased growth'. Together they form a unique fingerprint.

Medicine & Life Sciences